Skip to main content
Veterinary Medicines

Marbocare flavour 80 mg tablets for dogs

Authorised
  • Marbofloxacin

Product identification

Medicine name:
Marbocare flavour 80 mg tablets for dogs
Marbofloxacin WDT 80 mg aromatisierte Tabletten für Hunde
Active substance:
  • Marbofloxacin
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Marbofloxacin
    80.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Authorisation status:
  • Valid
Authorised in:
  • Austria
Available in:
  • Austria
Package description:
  • The product is packaged in Aluminium- PVC/aluminium/polyamide blister Box containing 2 blisters of 6 tablets (12 tablets)
  • The product is packaged in Aluminium- PVC/aluminium/polyamide blister Box containing 12 blisters of 6 tablets (72 tablets)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 835101
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0563/003
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
German (PDF)
Published on: 18/12/2018

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 26/03/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 26/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."